Clin2
NCT07841496Possibly a fitNot yet recruiting

Study of a new drug for stroke recovery after a past stroke

Ischemic Stroke in the Sequelae Stage

Treatments studied

Part of Brain & nervous system clinical trials.

This study tests an experimental drug called ALT001 for people who are still recovering from a stroke that happened at least 6 months ago and within the last 5 years. The drug may help improve limb weakness that persists after a stroke.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
200 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are between 18 and 80 years old.
  • Your most recent stroke happened at least 6 months ago and within the last 5 years.
  • You have weakness on one side of your body, but not too severe.
  • Before your stroke, you were independent in daily activities.
  • No stroke or heart-related events in the past 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07739160Not yet recruiting· Phase 2
A potential treatment for recent ischemic stroke

This study tests a new drug called HRS-4029 for people who have had an ischemic stroke (a stroke caused by a blocked blood vessel in the brain). The goal is to see if the drug can help improve recovery when given very soon after the stroke starts.

Beijing, Beijing Municipality
NCT07205328Recruiting· Phase 2
Testing MT200605 for acute ischemic stroke

This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.

Beijing, Beijing Municipality
NCT07754825Not yet recruiting· Phase 2
Investigational drug for recent ischemic stroke

This study tests an investigational injectable drug called LT3001 that may help dissolve blood clots in the brain after a stroke. It is given within 24 hours of stroke onset, and the goal is to reduce disability and improve recovery.

Beijing
NCT07742098Not yet recruiting· Phase 2
Study of an experimental drug for recovery after severe stroke

This trial tests an experimental drug given by IV to help people recover arm and leg movement after a severe stroke. It may help improve recovery in the early weeks after a stroke.

NCT05046106Not yet recruiting· Phase 2/Phase 3
Herbal medicine for stroke recovery

This study tests an herbal medicine (MLC1501) to see if it helps people recover better after a stroke. If you join, you'll take the medicine or a placebo (a pill with no active ingredient) while doing rehabilitation, and the study will track your recovery over time.

NCT06612710Recruiting· Phase 1
A study of NouvSoma001 for recent stroke recovery

This trial tests a new treatment called NouvSoma001 for people who have had an ischemic stroke within the last week. It aims to see if the treatment is safe and helps improve muscle strength and overall recovery.

Wuhan, Hubei

Hear when a new Ischemic Stroke in the Sequelae Stage trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.